Biotech Values

[DewDiligence]

Handicapping the Copaxone Patent Case

Inasmuch as several posters have weighed in with their probabilities
of NVS/MNTA’s succeeding on each of the individual arguments in
the patent case, I thought it was time for a scorecard.

 
             -Probably of NVS/MNTA Success- 
               CoM     Process    Overall     iHub 
             Patents   Patents   Litigation   Reference 
  
 exwannabe     68%       82%        56%       #msg-64399149 
 RockRat       78%       76%        59%       #msg-64420086 
 Dew            *         *         77%       #msg-59688565 
 investorgold   *         *         84%       #msg-64399885 
 zipjet         *         *          †        #msg-56326587

*Simplified model does not include separate analyses for CoM and process patents.
† “Significantly higher than 64%.”